Startups

Associate Director/Director, Medical Affairs – Publications

Braveheart · San Francisco, CA or Remote or Hybrid · Remote

← All jobs
About Braveheart

Advancing treatments to improve outcomes and quality of life for patients with hypertrophic cardiomyopathy and related heart conditions. Backed by a16z.

About the role

Position reports to the Head of Medical Affairs. This individual will own the publications function for BHB-1893, leading the strategy, planning, and execution of a multi-year publication and congress plan that builds the body of evidence supporting the global development and future launch of BHB-1893 for obstructive and non-obstructive hypertrophic cardiomyopathy (oHCM and nHCM). Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Advanced scientific degree (MD, PhD, PharmD, or equivalent)
  • Proven experience with strategic publication planning and execution across all phases of drug development, including high-impact journal manuscripts and major congress presentations
  • In-depth knowledge of GPP, ICMJE, CONSORT, and related guidance for scientific data communication
  • Solid understanding of clinical trial design, statistical methods, and clinical data reporting
  • Demonstrated success working in a matrixed, cross-functional environment and influencing without authority
  • Strong scientific writing, editing, and data interpretation skills, with the ability to translate complex data into clear, compelling communications
More about this role

Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart’s goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity.

With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area.

Position reports to the Head of Medical Affairs. This individual will own the publications function for BHB-1893, leading the strategy, planning, and execution of a multi-year publication and congress plan that builds the body of evidence supporting the global development and future launch of BHB-1893 for obstructive and...

Read the full posting on Braveheart's site ↗

Medical Affairs

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.